Alliancebernstein L.P. Argenx Se Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Argenx Se stock. As of the latest transaction made, Alliancebernstein L.P. holds 53,835 shares of ARGX stock, worth $43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,835

Previous 1,407 3726.23%

Holding current value

$43 Million

Previous $832,000 3466.59%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$532.27 - $656.65 $27.9 Million - $34.4 Million	52,428 Added 3726.23%	53,835 $29.7 Million
Q1 2025 May 15, 2025	SELL	$571.0 - $671.75 $10.8 Million - $12.7 Million	-18,883 Reduced 93.07%	1,407 $832,000
Q4 2024 Feb 12, 2025	SELL	$520.52 - $638.33 $689,168 - $845,148	-1,324 Reduced 6.13%	20,290 $12.5 Million
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $5.3 Million - $6.73 Million	12,198 Added 129.55%	21,614 $11.7 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $3.12 Million - $3.96 Million	8,766 Added 1348.62%	9,416 $4.05 Million
Q1 2024 May 14, 2024	SELL	$356.95 - $413.29 $2.64 Million - $3.06 Million	-7,407 Reduced 91.93%	650 $255,000
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $2.42 Million - $3.62 Million	-7,154 Reduced 47.03%	8,057 $3.07 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $498,253 - $739,832	-1,349 Reduced 8.15%	15,211 $7.48 Million
Q2 2023 Aug 15, 2023	BUY	$360.14 - $422.58 $2.82 Million - $3.31 Million	7,837 Added 89.84%	16,560 $6.45 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $604,622 - $730,202	-1,809 Reduced 17.18%	8,723 $3.25 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $1.28 Million - $1.5 Million	-3,732 Reduced 26.16%	10,532 $3.99 Million
Q3 2022 Nov 15, 2022	SELL	$343.2 - $395.75 $1.41 Million - $1.63 Million	-4,107 Reduced 22.36%	14,264 $5.04 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $2.38 Million - $3.35 Million	8,847 Added 92.89%	18,371 $6.96 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $2.42 Million - $3.34 Million	9,524 New	9,524 $3 Million
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $1.27 Million - $1.56 Million	-11,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $1.09 Million - $1.48 Million	11,000 New	11,000 $1.37 Million

Others Institutions Holding ARGX

# of Institutions

492

Shares Held

28.2M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Argenx Se Transaction History